About Xylia Pharmaceuticals Private Limited
Data last updated:
Xylia Pharmaceuticals Private Limited is a private limited company based in Kozhikode, Kerala, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 17 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U85100KL2015PTC039198. Its GSTIN is 32AAACX1853D1ZR (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Prabeesh (Managing Director) and Nechi Nechi Parambath Prashob (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kozhikode, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹71.26 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹1.22 Lakh (net margin 1.7%) and EBITDA of ₹1.75 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 2% over five years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website xyliapharma.com.
Company details
Contact details
Xylia Pharmaceuticals Private Limited's registered office is in Kozhikode, Kerala. Its website is xyliapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2/971 A (C) Ground Floor Suraksha Arcade Pm Kutty Road Eranzhipalam Po Nadakkav, U, Kozhikode, Kerala, India – 673006
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Xylia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xylia Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Xylia Pharmaceuticals Private Limited, buy the company report.
Financials of Xylia Pharmaceuticals Private Limited
FY 2025 filings availableXylia Pharmaceuticals Private Limited reported revenue of ₹71.26 Lakh (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xylia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Xylia Pharmaceuticals Private Limited
Xylia Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nechi Nechi Parambath Prashob | Whole-Time Director | 17 Sep 2015 | 11 Years 1 Months | Current |
| Prabeesh Also directs: Avalon Pharmacare LLP | Managing Director | 17 Sep 2015 | 11 Years 1 Months | Current |
Peer comparison
Xylia Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lucon Pharma and Research Private Limited | ₹71.82 Lakh (FY 2024) | 476.0% | Roorkee, Uttarakhand, India | |||
| Dorris Pharmaceuticals Private Limited | ₹71.6 Lakh (FY 2024) | -9.0% | Delhi, India | |||
| Xylia Pharmaceuticals Private Limitedthis company | ₹71.26 Lakh (FY 2025) | ₹1.22 Lakh | 1.7% | -7.0% | Kozhikode, Kerala, India | |
| Nevuron India Private Limited | ₹70.92 Lakh (FY 2025) | 20.0% | New Delhi, Delhi, India |
To see the full peer comparison of Xylia Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Xylia Pharmaceuticals Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Xylia Pharmaceuticals Private Limited, buy the company report.
Legal cases
Xylia Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Civil suit | Filed against the company by Alkem Laboratories Ltd | Pending |
To see the full case history of Xylia Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xylia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xylia Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAACX1853D1ZR | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Xylia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Xylia Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Nechi Nechi Parambath Prashob was appointed as Whole-Time Director on 17 Sep 2015.
Frequently asked questions
Xylia Pharmaceuticals is an active private limited company based in Kozhikode, Kerala, India. The company works in retail trading, within the trading industry. It was incorporated on 17 September 2015 (11+ years old) and is registered under CIN U85100KL2015PTC039198.
Xylia Pharmaceuticals has 2 current directors:
- Prabeesh - Managing Director
- Nechi Nechi Parambath Prashob - Whole-Time Director
The latest financial statements of Xylia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Xylia Pharmaceuticals is 32AAACX1853D1ZR, registered in Kerala.
The CIN (Corporate Identification Number) of Xylia Pharmaceuticals is U85100KL2015PTC039198. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xylia Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Xylia Pharmaceuticals was incorporated on 17 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Xylia Pharmaceuticals by revenue are Lucon Pharma and Research Private Limited, Dorris Pharmaceuticals Private Limited, Nevuron India Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Nechi Nechi Parambath Prashob was appointed as Whole-Time Director on 17 Sep 2015. Prabeesh was appointed as Managing Director on 17 Sep 2015.
Xylia Pharmaceuticals can be reached through the website xyliapharma.com. Its registered office is in Kozhikode, Kerala, India.
The registered office of Xylia Pharmaceuticals is at 2971 A C Ground Floor Suraksha Arcade Pm Kutty Road Eranzhipalam Po Nadakkav, U, Kozhikode, Kerala, India – 673006.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
